tiprankstipranks
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Technical Analysis

Compare
254 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Immunome’s (IMNM) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting Immunome is a Buy.
Immunome’s (IMNM) 20-Day exponential moving average is 10.47, while Immunome’s (IMNM) share price is $9.9, making it a Sell.
Immunome’s (IMNM) 50-Day exponential moving average is 10.88, while Immunome’s (IMNM) share price is $9.9, making it a Sell.

Immunome (IMNM) Pivot Points

Feb 20, 2025, 05:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.79
9.32
9.62
10.15
10.46
10.99
11.29
Fibonacci
9.32
9.64
9.83
10.15
10.47
10.67
10.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunome (IMNM) Moving Averages

Feb 20, 2025, 05:38 PM
Period
Simple
Exponential
MA5
10.21Sell
10.19Sell
MA10
10.67Sell
10.37Sell
MA20
10.41Sell
10.47Sell
MA50
10.99Sell
10.88Sell
MA100
11.64Sell
11.77Sell
MA200
12.95Sell
13.70Sell
Immunome’s (IMNM) 10-Day exponential moving average is 10.37, while Immunome’s (IMNM) share price is $9.9, making it a Sell.
Immunome’s (IMNM) 100-Day exponential moving average is 11.77, while Immunome’s (IMNM) share price is $9.9, making it a Sell.
Immunome’s (IMNM) stock price is $9.9 and Immunome’s (IMNM) 50-day simple moving average is 10.99, creating a Sell signal.
Immunome’s (IMNM) stock price is $9.9 and Immunome’s (IMNM) 100-day simple moving average is 11.64, creating a Sell signal.
Immunome’s (IMNM) stock price is $9.9 and Immunome’s (IMNM) 200-day simple moving average is 12.95, creating a Sell signal.

Immunome (IMNM) Technical Indicators

Feb 20, 2025, 05:38 PM
Name
Value
Implied Action
RSI (14)
43.40
Neutral
STOCH (9,6)
14.68
Buy
STOCHRSI (14)
29.24
Neutral
MACD (12,26)
-0.13
Buy
ADX (14)
18.69
Buy
Williams %R
-77.68
Buy
CCI (14)
-59.68
Neutral
ATR (14)
0.80
-
Ultimate Oscillator
43.50
Neutral
ROC
5.88
Buy
Immunome’s (IMNM) Relative Strength Index (RSI) is 43.40, creating a Neutral signal.
Immunome’s (IMNM) Trend Strength Indicator (ADX) is 18.69, creating a Buy signal.
Immunome’s (IMNM) Commodity Channel Index (CCI) is -59.68, creating a Neutral signal.
Immunome’s (IMNM) Price Rate of Change (ROC) is 5.88, creating a Buy signal.

FAQ

Is IMNM a Buy, Hold, or Sell?
Based on IMNM’s technical indicators, IMNM is a Sell.
    What is IMNM’s RSI (14)?
    IMNM’s RSI (14) is 43.40, which suggests IMNM is a Neutral.
      What is IMNM’s MACD?
      IMNM’s MACD is -0.13, which suggests IMNM is a Buy.
        What is IMNM’s 5-day moving average?
        IMNM’s 5-day moving average is 10.21, which suggests IMNM is a Sell.
          What is IMNM’s 20-day moving average?
          IMNM 20-day moving average is 10.41, which suggests IMNM is a Sell.
            What is IMNM’s 50-day moving average?
            IMNM’s 50-day moving average is 10.99, which suggests IMNM is a Sell.
              What is IMNM’s 200-day moving average?
              IMNM’s 200-day moving average is 12.95, which suggests IMNM is a Sell.
                What is IMNM’s Williams % R (14)?
                IMNM’s Williams % R (14) is -77.68, which suggests IMNM is a Buy.
                  What is IMNM’s CCI (14)?
                  IMNM’s CCI (14) is -59.68, which suggests IMNM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis